A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/155 (2006.01) A61K 31/365 (2006.01) A61K 31/47 (2006.01)
Patent
CA 2117592
N,N'-disubstituted guanidines exhibiting a high binding affinity to phencyclidine (PCP) receptors are disclosed. These N,N'-disubstituted guanidine derivatives act as non-competitive inhibitors of glutamate induced responses generated via the NMDA receptor by acting as blockers for the ion channel of the NMDA receptor-ion channel complex. These compounds thus exert a neuroprotective property and are useful in the therapeutic treatment of neuronal loss in hypoxia, hypoglycemia, brain or spinal cord ischemia, brain or spinal cord trauma, as well as being useful for the treatment of epilepsy, Alzheimer's disease, Amy- otrophic Lateral Sclerosis, Huntington's disease, Down's Syndrome, Korsakoff's disease and other neurodegenerative disorders.
Keana John F. W.
Weber Eckard
Acting For And On Behalf Of The Oregon Health Sciences Univer State Of Oregon Acting By And Through The Oregon State Board Of
Smart & Biggar
LandOfFree
N,n'-disubstituted guanidines and their use as excitatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N,n'-disubstituted guanidines and their use as excitatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N,n'-disubstituted guanidines and their use as excitatory... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2074216